Cargando…
Forced Degradation Testing as Complementary Tool for Biosimilarity Assessment
Oxidation of monoclonal antibodies (mAbs) can impact their efficacy and may therefore represent critical quality attributes (CQA) that require evaluation. To complement classical CQA, bevacizumab and infliximab were subjected to oxidative stress by H(2)O(2) for 24, 48, or 72 h to probe their oxidati...
Autores principales: | Dyck, Yan Felix Karl, Rehm, Daniel, Joseph, Jan Felix, Winkler, Karsten, Sandig, Volker, Jabs, Wolfgang, Parr, Maria Kristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783961/ https://www.ncbi.nlm.nih.gov/pubmed/31330921 http://dx.doi.org/10.3390/bioengineering6030062 |
Ejemplares similares
-
Pharmacovigilance Considerations for Biosimilars in the USA
por: Grampp, Gustavo, et al.
Publicado: (2015) -
An Orally Administered Nonpathogenic Attenuated Vaccine Virus Can Be Used to Control SARS-CoV-2 Infection: A Complementary Plan B to COVID-19 Vaccination
por: Bakacs, Tibor, et al.
Publicado: (2022) -
Toolbox approach for fast generation of stable CHO production cell lines from different hosts
por: Seitz, Susanne, et al.
Publicado: (2011) -
Bioengineering of rFVIIa Biopharmaceutical and Structure Characterization for Biosimilarity Assessment
por: Montacir, Othman, et al.
Publicado: (2018) -
A robust RMCE system based on a CHO-DG44 platform enables efficient evaluation of complex biological drug candidates
por: Rose, Thomas, et al.
Publicado: (2013)